A patent ruling has delivered a serious blow to one US state's hopes of a biotechnology boom. Erika Check reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Licensing fees slow advance of stem cells
www.nature.com/news/infocus/stemcells.html
Related external links
California Institute For Regenerative Medicine
Rights and permissions
About this article
Cite this article
Patenting the obvious?. Nature 447, 16–17 (2007). https://doi.org/10.1038/447016a
Published:
Issue Date:
DOI: https://doi.org/10.1038/447016a
This article is cited by
-
Stem-cell researcher's move attracts funding
Nature (2007)
-
A patent challenge for human embryonic stem cell research
Nature Reports Stem Cells (2007)